Potential benefits from currently available three pneumococcal vaccines for children - Population-based evaluation

Klinische Padiatrie

Volumn 223, Issue 2, 2011, Pages 61-64

  Ruckinger S ^a   Van Der Linden, M ^b   Siedler, A ^c   Von Kries, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b University Hospital   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

epidemiology; incidence; invasive pneumococcal disease; pneumococcal conjugate vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; CHILD; CHILD HEALTH CARE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; GERMANY; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; PNEUMOCOCCAL INFECTION; POPULATION RESEARCH; PRESCHOOL CHILD; RISK REDUCTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPITOPES; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 79953059965     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1268465     Document Type: Article

References (20)

1. Black S. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation. Pediatr Infect Dis J 2010 29 301-303
2. Centers for Disease Control and Prevention (CDC). Invasive Pneumococcal Disease in Children 5 Years After Conjugate Vaccine Introduction - Eight States, 1998-2005. Morb Mortal Wkly Rep 2008 57 144-148
3. Choi EH, Kim SH, Eun BW et al,. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008 14 275-281
4. Gobel U, Heinrich B, Krauth KA et al,. [Process and outcome quality of the German Paediatric Surveillance Unit (ESPED)]. Klin Padiatr 2010 222 92-97
5. Harboe ZB, Valentiner-Branth P, Benfield TL et al,. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 2010 28 2642-2647
6. Jefferson T. Pneumococcal vaccines: confronting the confounders. Lancet 2009 373 2008-2009
7. Neufeld F. ber die Agglutination der Pneumokokken und über die Theorie der Agglutination. Z Hyg Infektionskr 1902 40 54-72
8. Robert Koch Institut. Empfehlungen der Stndigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2006. Epidemiologisches Bulletin 2006 30 267-286
9. Robert Koch Institut. Begründung der STIKO-Empfehlungen zur Impfung gegen Pneumokokken und Meningokokken vom Juli 2006. Epidemiologisches Bulletin 2006 31 255-270
10. Robert Koch Institut. Laborsentinel zur Erfassung invasiver Pneumokokken ist gestartet. Epidemiologisches Bulletin 2007 4 27
11. Robert Koch Institut. Neuerungen in den aktuellen Empfehlungen der Stndigen Impfkommission (STIKO) am RKI vom Juli 2010. Epidemiologisches Bulletin 2010 33 331-340
12. Rückinger S, van der Linden M, Reinert RR et al,. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method. Vaccine 2010 28 5012-5016
13. Rückinger S, von Kries R, Reinert RR et al,. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination. Vaccine 2008 26 3984-3986
14. Rückinger S, van der Linden M, Reinert RR et al,. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009 27 4136-4141
15. Schuerman L, Borys D, Hoet B et al,. Prevention of otitis media: now a reality? Vaccine 2009 27 5748-5754
16. Vestrheim DF, Hoiby EA, Bergsaker MR et al,. Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine 2010 28 2214-2221
17. Von Kries R, Heinrich B, Hermann M. Pdiatrische Epidemiologie in Deutschland: Forschungsinstrument ESPED (Erhebungseinheit für seltene pdiatrische Erkrankungen in Deutschland). Monatsschr Kinderheilkd 2001 149 1191-1197 (Pubitemid 33143900)
18. von Kries R, Siedler A, Reinert RR. Systemische Pneumokokken-Erkrankungen bei Kindern in Deutschland 1997-2003. Kinderrztl Praxis 2007 78 10-13
19. World Health Organization (WHO). 23-valent pneumococcal polysaccharide vaccine - WHO position paper. Wkly Epidemiol Rec 2008 42 373-384
20. Ziegler B, Strassburg HM. Vaccination status in very and extremely preterm infants at the age of 2 years - a nationwide pilot analysis. Klin Padiatr 2010 222 243-247